JPWO2023143227A5 - - Google Patents
Info
- Publication number
- JPWO2023143227A5 JPWO2023143227A5 JP2024543357A JP2024543357A JPWO2023143227A5 JP WO2023143227 A5 JPWO2023143227 A5 JP WO2023143227A5 JP 2024543357 A JP2024543357 A JP 2024543357A JP 2024543357 A JP2024543357 A JP 2024543357A JP WO2023143227 A5 JPWO2023143227 A5 JP WO2023143227A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- variable region
- chain variable
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210098976 | 2022-01-25 | ||
| CN202210098976.1 | 2022-01-25 | ||
| PCT/CN2023/072527 WO2023143227A1 (zh) | 2022-01-25 | 2023-01-17 | 抗cd73抗体及应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025504496A JP2025504496A (ja) | 2025-02-12 |
| JP2025504496A5 JP2025504496A5 (https=) | 2026-01-06 |
| JPWO2023143227A5 true JPWO2023143227A5 (https=) | 2026-01-06 |
Family
ID=87470540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543357A Abandoned JP2025504496A (ja) | 2022-01-25 | 2023-01-17 | 抗ｃｄ７３抗体及び使用 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4471062A4 (https=) |
| JP (1) | JP2025504496A (https=) |
| KR (1) | KR20240139053A (https=) |
| CN (1) | CN118591559A (https=) |
| AU (1) | AU2023212216A1 (https=) |
| WO (1) | WO2023143227A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119744177A (zh) * | 2023-07-24 | 2025-04-01 | 石药集团巨石生物制药有限公司 | 重组人源化抗cd73单克隆抗体的药物组合物 |
| WO2025125545A1 (en) * | 2023-12-15 | 2025-06-19 | Sanofi | Effectorless igg1 fc variants |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3218406T4 (da) | 2014-11-10 | 2024-12-09 | Medimmune Ltd | Bindingsmolekyler, der er specifikke for cd73, og anvendelser deraf |
| MY189836A (en) * | 2014-11-21 | 2022-03-11 | Bristol Myers Squibb Co | Antibodies against cd73 and uses thereof |
| KR20230038311A (ko) * | 2016-03-04 | 2023-03-17 | 브리스톨-마이어스 스큅 컴퍼니 | 항-cd73 항체와의 조합 요법 |
| EP3383916B1 (en) | 2017-01-24 | 2022-02-23 | I-Mab Biopharma US Limited | Anti-cd73 antibodies and uses thereof |
| EP3569618A1 (en) * | 2018-05-19 | 2019-11-20 | Boehringer Ingelheim International GmbH | Antagonizing cd73 antibody |
-
2023
- 2023-01-17 EP EP23746109.0A patent/EP4471062A4/en active Pending
- 2023-01-17 CN CN202380018508.1A patent/CN118591559A/zh active Pending
- 2023-01-17 JP JP2024543357A patent/JP2025504496A/ja not_active Abandoned
- 2023-01-17 WO PCT/CN2023/072527 patent/WO2023143227A1/zh not_active Ceased
- 2023-01-17 AU AU2023212216A patent/AU2023212216A1/en active Pending
- 2023-01-17 KR KR1020247024203A patent/KR20240139053A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2021531005A5 (https=) | ||
| JP2021524249A5 (https=) | ||
| RU2019141289A (ru) | АНТИ-SIRPα АНТИТЕЛА | |
| CA2987118A1 (en) | A pdl-1 antibody, pharmaceutical composition thereof and use thereof | |
| JP2026041845A5 (https=) | ||
| JPWO2019224717A5 (https=) | ||
| JP2021515541A5 (https=) | ||
| AU2022332499A1 (en) | Fap/cd40 binding molecule and medicinal use thereof | |
| JP2021515542A5 (https=) | ||
| JPWO2021104302A5 (https=) | ||
| JP2025511288A (ja) | 抗ｐｖｒｉｇ抗体、その医薬組成物及びその使用 | |
| US20230340119A1 (en) | Composition of triax antibodies and method of making and using thereof | |
| JPWO2019170898A5 (https=) | ||
| JP2021514654A5 (https=) | ||
| JPWO2020185722A5 (https=) | ||
| JPWO2023143227A5 (https=) | ||
| RU2024116190A (ru) | Антитело против cd73 и его применение | |
| JPWO2019170885A5 (https=) | ||
| JPWO2023051683A5 (https=) | ||
| RU2025134255A (ru) | Конъюгат антитела к рецептору эпидермального фактора роста (egfr) и лекарственного средства и его применение | |
| JPWO2019166596A5 (https=) | ||
| RU2025134256A (ru) | Конъюгат антитела к pdl1 и лекарственного средства и применение | |
| JPWO2022242681A5 (https=) | ||
| RU2025136924A (ru) | Антитела против клаудина 18.2 и способы их получения и применения |